McEwen Centre for Regenerative Medicine

AnaBios Brings In $10m Series B Round, Including $4.2m From Principia AnaBios Corp. (focused on pain and cardiovascular and neurodegenerative diseases) closed a $10m Series B round, which included

Mergers & Acquisitions

by Cheri Thompson Advances in Cell Therapy & Regenerative Medicine From Skin Cells to Heart Cells Researchers at the University of California, Los Angeles (UCLA) recently reported that they were a

In Vitro Diagnostics Lipomics Technologies Inc. Harvard University Harvard Medical School Joslin Diabetes Center Lipomics, Joslin Diabetes Center study insulin resistance Feb. — Lipomics Technologies